Britain has spent the last three decades asking individuals to make healthier choices inside a market that makes those choices more expensive and less visible. It is no surprise then that the proportion of adults in England living with obesity nearly doubled in that time, to 30%. MPs on the health select committee have decided enough is enough. Preventing obesity in future generations, they say, must take precedence over the interests of the food and drink industry.
In a report to parliament, the cross-party committee argues that preventing obesity demands radical action to regulate food markets. To those who say “just wait for cheap Ozempic”, MPs offer a clear answer: off-patent GLP-1 drugs may transform treatment, but treatment is what becomes necessary when prevention has failed.
